Capricor Therapeutics Inc ( NASDAQ:CAPR – Get Rating ) was the target of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 294,800 shares, a growth of 11.0% from the April 30th total of 265,700 shares. Based on an average daily volume of 72,100 shares, the short-interest ratio is currently 4.1 days. Analysts Set New Price Targets A number of brokerages have recently commented on CAPR. HC Wainwright restated a 'buy' rating and issued a $18.

https://www.dailypolitical.com/2023/05/31/capricor-therapeutics-inc-nasdaqcapr-short-interest-update.html

#dailypolitical